Berlin, Feb 1 (EFE).- United States pharmaceutical company Pfizer and their German partner BioNTech on Monday announced they would supply the European Union with 75 million additional vaccine doses in the second quarter of 2021 after optimizing production processes.
The companies plan to “increase deliveries from the week beginning February 15” and supply “the number of doses we committed to in the first quarter,” the company’s chief financial officer, Sierk Poetting, said in a statement.
The firm’s announcement came before a summit on vaccinations on Sunday convened by the German government, with representatives from six pharmaceutical companies and the EU, which has faced some criticism for its slow vaccine rollout.
Pfizer/BioNtech, Moderna and AstraZeneca have had production problems in the EU, delaying vaccine supplies to member states. Pfizer/BioNtech says it will now be able to ramp up production, according to Poetting, because optimization work at the Belgian Purus plant has been completed.EFE